Sort
48,018 grants matching “immunotherapy”
Developing Immune Based Therapies
$686,322Crystal Mackall · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Novel Approaches to CD33-Directed Radioimmunotherapy
$686,273Roland Bruno Walter · Fred Hutchinson Cancer Research Center · R37 · FY2020 · CA
METABOLIC REMODELING OF THE TUMOR MICROENVIRONMENT TO IMPROVE THE EFFICACY OF IMMUNOTHERAPY
$686,179University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2018 · Department of the Army
HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer
$686,087Amir Horowitz · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancer
$686,036Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DE
Miami Pediatric AIDS Clinical Trials Unit
$686,001University Of Miami School Of Medicine · U01 · FY2004 · AI
Administrative Core
$685,965Jun Yan · University Of Louisville · P20 · FY2023 · GM
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
$685,920Carol A Kruse · University Of California Los Angeles · R01 · FY2012 · CA
Cancer Stem Cells in Cholangiocarcinoma
$685,872Changqing Xie · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells
$685,832Sandra Aung · Ubivac, Llc · R44 · FY2010 · CA
Home-based actigraphy to predict disability progression and enhance clinical trials in multiple sclerosis
$685,681Ellen M. Mowry · Johns Hopkins University · R01 · FY2021 · NR
Design and characterization of biomimetic nanobiomaterials to elicit CD1-restricted T cell responses during sub-unit vaccination
$685,339Evan Alexander Scott · Northwestern University · R01 · FY2020 · AI
Design and characterization of biomimetic nanobiomaterials to elicit CD1-restricted T cell responses during sub-unit vaccination
$685,339Evan Alexander Scott · Northwestern University · R01 · FY2019 · AI
Retinal Circuitry
$685,322Bryan William Jones · Utah State Higher Education System--University Of Utah · R01 · FY2025 · EY
Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens
$685,130Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
The Molecular Profile of Prostate Tumors in African-American Men
$685,102Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
A Cytomegalovirus-based therapeutic vaccine for chronic hepatitis B
$685,089Eric Bruening · Tomegavax, Inc. · R44 · FY2018 · AI
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$684,901Michael Lenardo · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
CD137 AS A TARGET FOR THE IMMUNOTHERAPY OF CANCER
$684,788Daniel G. Schindler · Gtc Biotherapeutics, Inc. · R44 · FY2007 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$684,659Udai S Kammula · Basic Sciences · Z01 · FY2007 · CA
Development of Immunotherapy Strategies for Gastrointestinal Cancers with focus
$684,659Udai S Kammula · Basic Sciences · Z01 · FY2007 · CA
Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity
$684,604Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity
$684,604Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy
$684,576Kosj Yamoah · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2022 · CA
Biochemical and cellular analysis of regulatory T cells reactive to a natural self antigen
$684,530Erin June Adams · University Of Chicago · R01 · FY2016 · AI